Collection of Gastrointestinal Malignant and Non-malignant Human Samples

Status unconfirmed

Conditions studied: Inflammatory Bowel Diseases, Colo-rectal Cancer

In brief

To collect human tissue, blood, and fecal samples from patients suffering from Inflammatory Bowel Disease and Colorectal Cancer. The samples will be used to establish biomimetic human organ-on-a-chip technology, as well as study the role of the microbiome in the pathogenesis in human gastrointestinal diseases.

Key facts

Study ID

NCT03415919

Run by

University of Texas at Austin

People needed

300

Starts

2018-07-13

Expected to finish

2022-07-01

Last updated by the study team

2021-06-16

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Biopsy-proven colorectal cancer scheduled to have surgical resection of primary site, at participating and approved facilities. Since it is standard clinical care to resect certain suspicious gastrointestinal masses without a pre-existing biopsy, patients who are undergoing resections for highly suspicious masses believed to be cancer, may be consented.
• Diagnosed with Inflammatory Bowel Disease (IBD) or Crohn's Disease (CD), scheduled to have biopsy and/or fecal collection.
• scheduled to have a colonoscopy as part of routine screening.
• 18 years old.
• Ability to understand and willingness to sign a written informed consent document.

You may not qualify if…

• The study will not exclude potential subjects from participation on the basis of ethnic origin or gender. Subjects recruited will include men, women, and all ethnic origins, provided they meet all inclusion criteria listed above.

Where it is running

• The University of Texas — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.